FDA advisors recommend Eli Lilly’s Alzheimer’s drug donanemab, paving way for approval CNBCOpinion | An Alzheimer’s Advance, Not a Cure-All The Wall Street JournalAlzheimer’s drug that can slow disease gets backing from FDA advisers Yahoo FinanceEli Lilly’s donanemab, an Alzheimer’s drug, gets FDA endorsement USA TODAY